APA (7th ed.) Citation

A, J., K, V., L, W., J, T., D, D., SA, G., & MF, L. (2025). A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023. Journal of cardiovascular pharmacology, 85(2), 97. https://doi.org/10.1097/FJC.0000000000001660

Chicago Style (17th ed.) Citation

A, Jallorina, Vij K, Wan L, Thomas J, Drum D, Glick SA, and Lee-Wong MF. "A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023." Journal of Cardiovascular Pharmacology 85, no. 2 (2025): 97. https://doi.org/10.1097/FJC.0000000000001660.

MLA (9th ed.) Citation

A, Jallorina, et al. "A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights From 2013 to 2023." Journal of Cardiovascular Pharmacology, vol. 85, no. 2, 2025, p. 97, https://doi.org/10.1097/FJC.0000000000001660.